ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Listed For January

January 28, 2005

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

ACS Asks Higher NCI Authorization

March 24, 1978

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014